tci Medicare Compliance & Reimbursement - 2003 Issue 17
Medicare Pass-Through: ANEMIA DRUG DISPUTE FILLS CMS MAILBAG
Subscribe or sign in to view the full article.
Article Overview
This article examines a Medicare outpatient prospective payment system policy dispute involving CMS pass-through payments for outpatient drugs and related stakeholder criticism of CMS eligibility standards. It is relevant to hospital outpatient billing, health policy, and pharmaceutical reimbursement professionals who monitor CMS rulemaking, Medicare payment policy, and the impact of drug coverage changes on outpatient reimbursement.
Why This Topic Matters
It highlights how CMS payment policy for new outpatient drugs can affect reimbursement decisions, stakeholder comments, and broader Medicare hospital outpatient funding priorities.
What You Will Learn
- How CMS outpatient drug pass-through payment policy is being challenged
- Why hospital outpatient prospective payment system policy changes attract bipartisan attention
- How Medicare drug payment policy can affect manufacturers, providers, and broader reimbursement priorities
- What kinds of stakeholders are involved in comments and lobbying around outpatient drug coverage
Who Should Read This
- Hospital outpatient coding and billing staff
- Health policy analysts
- Medicare reimbursement professionals
- Pharmaceutical reimbursement teams
- Compliance and revenue cycle teams
Subscribe or sign in to view the full article.
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Quick, Current, Complete - www.findacode.com